NCT03934684 2025-08-06Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple MyelomaAmgenPhase 4 Completed101 enrolled 11 charts
NCT06409702 2025-06-12Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease DetectionThe First Affiliated Hospital of Soochow UniversityPhase 4 Recruiting59 enrolled